Skip to main content
logo
Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
18.58
-0.11 (-0.59%)
At close: Oct 5, 2026, 4:00 PM EDT
19.00
+0.42 (2.26%)
After-hours: Oct 5, 2026, 4:43 PM EDT

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,099506138153437433
Market Cap Growth
308.51%266.35%-9.38%-65.05%0.75%-
Enterprise Value
63633910829341225
Last Close Price
18.6913.0822.2045.00133.00232.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.081.431.011.742.00
P/TBV Ratio
--1.431.011.742.00

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.01-0.020.330.240.160.08
Net Debt / Equity Ratio
2.312.75-0.62-0.67-0.76-0.88
Net Debt / EBITDA Ratio
3.951.330.510.832.112.80
Net Debt / FCF Ratio
3.293.150.601.002.042.59
Quick Ratio
18.7918.094.948.8117.5520.43
Current Ratio
19.1518.205.199.0418.0621.12
Return on Equity (ROE)
---94.52%-58.74%-39.45%-52.09%
Return on Assets (ROA)
-21.37%-70.41%-44.42%-31.67%-21.55%-27.09%
Return on Capital Employed (ROCE)
-25.70%-77.90%-97.50%-69.00%-32.60%-29.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
55.83%-137.42%-84.57%-77.25%-21.09%-15.90%
FCF Yield
-12.52%-28.36%-72.25%-66.44%-21.44%-16.86%
Buyback Yield / Dilution
-540.03%-187.35%-2.26%-69.88%-18.30%-15547.86%
SEC Filings: 10-K · 10-Q